نتائج البحث - "Emile E. Voest"

1

Tumor organoids: Opportunities and challenges to guide precision medicine

المؤلفون: Emile E. Voest, Vivien Veninga

المصدر: Cancer Cell. 39:1190-1201

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b71e8029f288b0993f582e3218b1eeTest
https://doi.org/10.1016/j.ccell.2021.07.020Test

2

Limited evolution of the actionable metastatic cancer genome under therapeutic pressure

المؤلفون: Egbert F. Smit, Henk M.W. Verheul, Martijn P. Lolkema, Lodewyk F. A. Wessels, Paul Roepman, Edwin Cuppen, Hans Gelderblom, Adrianus J. de Langen, Joris van de Haar, L.R. Hoes, Emile E. Voest

المساهمون: Medical Oncology

المصدر: Nature Medicine, 27, 9, pp. 1553-1563
Nature Medicine, 27, 1553-1563
Nature Medicine, 27(9), 1553-1563. Nature Publishing Group
Nature Medicine, 27(9), 1553-+. NATURE PORTFOLIO

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36328501c11d902b4af10bccb851ae3dTest
http://www.scopus.com/inward/record.url?scp=85112662777&partnerID=8YFLogxKTest

3

Developing and validating model systems for immuno-oncology

المؤلفون: Elad Sharon, Nastaran Zahir, Emile E. Voest, Claire E. McCarthy, Karolina Palucka, Mariam Eljanne

المصدر: Cancer Cell. 39:1018-1022

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4729fa8606454a31bb5abfaf18cea460Test
https://doi.org/10.1016/j.ccell.2021.05.017Test

4

Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

المؤلفون: Derk Jan A. de Groot, Anne M.L. Jansen, Mariette Labots, Wendy W.J. de Leng, Hanneke van der Wijngaart, Ann Hoeben, L.J. Zeverijn, Hans Gelderblom, Henk M.W. Verheul, Debbie Robbrecht, L.R. Hoes, Emile E. Voest, Erik van Werkhoven, Daphne L. van der Velden, J. Maxime van Berge Henegouwen, Paul Roepman, Paul Hamberg, Niven Mehra

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, Hematology, Research & Education, Neurology, Medical Oncology, Radiology and Nuclear Medicine, Graduate School, APH - Methodology, APH - Personalized Medicine

المصدر: Clinical Cancer Research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Clinical Cancer Research, 27, 6106-6114
Clinical Cancer Research, 27(22), 6106-6114. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research : an official journal of the American Association for Cancer Research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Van Der Wijngaart, H, Hoes, L R, Van Berge Henegouwen, J M, Van Der Velden, D L, Zeverijn, L J, Roepman, P, Van Werkhoven, E, De Leng, W W J, Jansen, A M L, Mehra, N, Robbrecht, D G J, Labots, M, De Groot, D J A, Hoeben, A, Hamberg, P, Gelderblom, H, Voest, E E & Verheul, H M W 2021, ' Patients with Biallelic BRCA1/2 Inactivation respond to Olaparib treatment across Histologic tumor types ', Clinical Cancer Research, vol. 27, no. 22, pp. 6106-6114 . https://doi.org/10.1158/1078-0432.CCR-21-1104Test
Clinical cancer research, 27(22), 6106-6114. American Association for Cancer Research Inc.
Clinical Cancer Research, 27, 22, pp. 6106-6114

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, MAINTENANCE THERAPY, MULTICENTER, HOMOLOGY-DIRECTED REPAIR, OVARIAN-CANCER, VALIDATION, Olaparib, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], chemistry.chemical_compound, DOUBLE-BLIND, All institutes and research themes of the Radboud University Medical Center, Stable Disease, SDG 3 - Good Health and Well-being, Internal medicine, Clinical endpoint, Medicine, BREAST-CANCER, Loss function, 2-STAGE DESIGNS, business.industry, Wnt signaling pathway, Cancer, medicine.disease, RISKS, chemistry, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], PARP inhibitor, Toxicity, SENSITIVITY, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c98f524eeae4d08d3446ab9d9820a5Test
https://cris.maastrichtuniversity.nl/en/publications/6d297817-2a7a-4ceb-a790-898d766dde2fTest

5

Pan-cancer whole-genome analyses of metastatic solid tumours

المساهمون: Medical Oncology, Medical oncology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Pulmonary medicine, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Nature
Priestley, P, Baber, J, Lolkema, M P, Steeghs, N, de Bruijn, E, Shale, C, Duyvesteyn, K, Haidari, S, van Hoeck, A, Onstenk, W, Roepman, P, Voda, M, Bloemendal, H J, Tjan-Heijnen, V C G, van Herpen, C M L, Labots, M, Witteveen, P O, Smit, E F, Sleijfer, S, Voest, E E & Cuppen, E 2019, ' Pan-cancer whole-genome analyses of metastatic solid tumours ', Nature, vol. 575, no. 7781, pp. 210-216 . https://doi.org/10.1038/s41586-019-1689-yTest
Nature, 575(7781), 210. Nature Publishing Group
Nature, 575, 210-216
Nature, 575(7781), 210-216. Nature Publishing Group
Nature, 575, 7781, pp. 210-216

مصطلحات موضوعية: Oncology, Male, SELECTION, VARIANTS, Genome, Germline, 0302 clinical medicine, INDEL Mutation, Neoplasms, Gene duplication, Cancer genomics, HETEROGENEITY, Neoplasm Metastasis, Precision Medicine, Non-U.S. Gov't, Cause of death, 0303 health sciences, Multidisciplinary, Research Support, Non-U.S. Gov't, 3. Good health, 030220 oncology & carcinogenesis, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.medical_specialty, DNA Copy Number Variations, GENETICS, Research Support, Article, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, GERMLINE, medicine, Journal Article, Humans, General, Gene, 030304 developmental biology, Whole genome sequencing, Whole Genome Sequencing, LANDSCAPE, business.industry, Information Dissemination, MUTATIONS, Precision medicine, EVOLUTION, Clone Cells, Clinical trial, Mutation, PATTERNS, UPDATE, business

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151dfcf6ddc15faa4370dbff734c9c5fTest
http://europepmc.org/articles/PMC6872491Test

6

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

المصدر: Nature Medicine. 26:992-994

مصطلحات موضوعية: medicine.medical_specialty, business.industry, MEDLINE, Cancer, General Medicine, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Core (game theory), Clinical decision making, Precision oncology, medicine, Tumor board, Medical physics, Support system, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f7aa80ba929c8239b5bfb6588b5bede9Test
https://doi.org/10.1038/s41591-020-0969-2Test

7

Abstract GS1-07: The genomic landscape of 501 metastatic breast cancer patients

المؤلفون: Stefan Sleijfer, Neeltje Steeghs, Jwm Martens, Emile E. Voest, J. van Riet, Martijn P. Lolkema, Saskia M Wilting, Tessa G Steenbruggen, Haiko J. Bloemendal, Mariette Labots, VC Tjan-Heijnen, JM van Riel, A. Jager, Lindsay Angus, H.J.G. van de Werken, Edwin Cuppen, Marcel Smid

المصدر: Cancer Research. 79:GS1-07

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0befd148230f72bb6b0bbda61af5b3f6Test
https://doi.org/10.1158/1538-7445.sabcs18-gs1-07Test

8

Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study

المؤلفون: Kathleen J. Yost, Emile E. Voest, Katherine A. Janeway, Ajjai Alva, Edward S. Kim, Richard L. Schilsky, Philip J. Stella, Suanna S. Bruinooge, Pam K. Mangat, Navin R. Pinto, Elizabeth Garrett-Mayer, Susan Halabi, Jane Perlmutter

المصدر: JCO Precision Oncology. :1-14

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709443869677d2d9f485f5551ccc7d4eTest
https://doi.org/10.1200/po.18.00122Test

9

Prospective experimental treatment of colorectal cancer patients based on organoid drug responses

المساهمون: Graduate School, APH - Methodology, APH - Personalized Medicine, Radiology and Nuclear Medicine

المصدر: Esmo Open, 6, 3
Esmo Open, 6
ESMO open, 6(3):100103. Elsevier BV
ESMO Open

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e074f5b1f56474c3a7d338d9fa19eadTest
https://repository.ubn.ru.nl/handle/2066/235053Test

10

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)

المؤلفون: Luuk J. Schipper, Paul Roepman, Kris G. Samsom, Ewart de Bruijn, Valesca P. Retèl, Kim Monkhorst, Lieke Schoenmaker, Gerrit A. Meijer, Lizet E. van der Kolk, L.R. Hoes, Geert W.J. Frederix, Edwin Cuppen, Emile E. Voest, Immy Riethorst, Jacobus J M van der Hoeven, Linda J.W. Bosch, Tineke E. Buffart

المساهمون: Health Technology Assessment (HTA)

المصدر: BMC Medical Genomics
BMC Medical Genomics, 13
BMC Medical Genomics, 13, 1
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-7 (2020)
BMC Medical Genomics, 13(1). BioMed Central Ltd.

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, lcsh:Internal medicine, Technology Assessment, Biomedical, lcsh:QH426-470, Clinical Decision-Making, Single test, Specimen Handling, Workflow, 03 medical and health sciences, Study Protocol, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Neoplasms, Cancer centre, Genetics, medicine, Biomarkers, Tumor, Humans, Medical physics, Clinical efficacy, Precision Medicine, lcsh:RC31-1245, Diagnostics, Genetics (clinical), Cancer, Protocol (science), Whole Genome Sequencing, business.industry, Patient Selection, Health technology, Standard of Care, DNA, Neoplasm, Biomarker, Molecular diagnostics, Personalized medicine, lcsh:Genetics, Observational Studies as Topic, 030104 developmental biology, Molecular Diagnostic Techniques, Research Design, 030220 oncology & carcinogenesis, Feasibility Studies, Performance indicator, business, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ad7fa087dabf42a5c133879f913214Test
https://pubmed.ncbi.nlm.nih.gov/33167975Test

تنقيح النتائج